This website uses cookies to improve the functionality and performance of the website, to better understand how you use AAPA’s website and services, and to provide you with a customized experience. By continuing your use of this website, you consent to this use of cookies. See our Privacy Policy for more information.
The American Academy of Physician Associates (AAPA) today commended the Centers for Medicare & Medicaid Services (CMS) for incentivizing optimal practice environments in its newly released Rural Health Transformation Program Notice of Funding Opportunity (NOFO).
AAPA responds to 2026 Physician Fee Schedule proposed rule, calling on CMS to maintain transparency in PA service attribution, reduce administrative burdens, and improve patient access to care.
AAPA recently filed comments in response to the 2026 Home Health Prospective Payment System Rate Update proposed rule, urging the Department of Health and Human Services (HHS) to address several outdated policies creating inefficiency in care delivery.
To support PAs and PA administrators with navigating changes in the healthcare reimbursement environment put into effect by the One Big Beautiful Bill Act (H.R.1), AAPA has prepared an overview of our extensive resources containing up-to-date guidance on reimbursement policies.
AAPA has prepared an overview to ensure the PA community remains fully informed about the impact of the One Big Beautiful Bill Act (H.R. 1) on PAs and their patients.
To close out the first half of the year, we're highlighting some of the Advocacy team's recent successes and engagements at the federal and state levels.
Over the last several weeks, AAPA submitted a series of comments to multiple agencies addressing topics ranging from anticompetitive practices against PAs to opportunities to improve policies in skilled nursing facilities, inpatient rehabilitation facilities, inpatient psychiatric facilities, and hospice. In addition, AAPA raised attention to regulatory and policy barriers that limit PA practice and impose administrative burdens in letters to HHS, CMS, FDA, and OMB.